ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

High expression of ZFP36L2 correlates with the prognosis and immune infiltration in lower-grade glioma

Zhou, Min*; Li, Jinquan; Chen, Cheng*wuhan univ sci & technol
Frontiers in Genetics2022-7-15DOI: 10.3389/fgene.2022.914219
9阅读
引用收藏
分享

摘要

Background: The ZFP36 Ring Finger Protein Like 2 (ZFP36L2) is an RNA-binding protein that regulates gene expression at post-transcriptional level. However, the clinical significance and prognostic value of ZFP36L2 in lower-grade glioma (LGG) remain unclear. Method: ZFP36L2 expression was investigated using public datasets and the prognostic merit of ZFP36L2 with LGG patients was further evaluated. The correlation between the genetic alteration of ZFP36L2 and its mRNA expression was accessed via cBioPortal. Additionally, the prognostic value of the ZFP36L2 methylation levels in LGG was evaluated by MethSurv. The potential biological role of ZFP36L2 in LGG was identified by performing functional analyses. We also examined the correlation between ZFP36L2 expression and the immune infiltration. Finally, the predictive value of ZFP36L2 to immunotherapy was assessed. Result: ZFP36L2 was highly expressed in LGG patients and overexpressed ZFP36L2 predicted poor clinical outcomes. We further identified ZFP36L2 as an independent prognostic factor. The methylation level of ZFP36L2 negatively correlated with the ZFP36L2 expression, and patients with low ZFP36L2 methylation had worse overall survival. The results of functional analysis indicated that ZFP36L2 was involved in multiple immune response-related pathways in LGG. Furthermore, high expression of ZFP36L2 was significantly and positively correlated with immune infiltration. Finally, we found that ZFP36L2 expression was positively correlated with the immune checkpoint PD-L1, and ZFP36L2 low expression cohort gained better benefit from immunotherapy. Conclusion: Our findings demonstrate that ZFP36L2 is a potential biomarker for LGG, highlighting its potential as a therapeutic target in immunotherapy.

学科与关键词

关键词
ZFP36 ringfinger protein like 2 (ZFP36L2lower-grade gliomasimmune infiltrationprognostic valueTCGA
相关
加载中…
  • PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
    Li, Peng; Chen, Fanfan; Yao, Chen; Zhu, Kezhou; Zhang, Bei; Zheng, Zelong*Brain Sciences, 2022, 12(6): 763.被引 2
  • ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy
    Cheng, Xingbo; Liu, Zhendong; Liang, Wenjia; Zhu, Qingyun; Wang, Chao; Wang, Hongbo; Zhang, Jiangfen; Li, Pengxu; Gao, Yanzheng*International Journal of Biochemistry and Cell Biology, 2023, 158: 106409.被引 3
  • GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor
    Guo, Longbin; Chen, Yulei; Hu, Shushu; Gao, Lianxuan; Tang, Nan; Liu, Rongping; Qin, Yue; Ren, Chen*; Du, Shasha*CNS Neuroscience & Therapeutics, 2022, 28(1): 158-171.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-07-15
卷期
第 13 卷
页码
914219
DOI
10.3389/fgene.2022.914219
期刊等级
3区
成果收录
SCIE

作者

  • Z

    Zhou, Min (通讯) (第一作者)

    wuhan univ sci & technol

  • L

    Li, Jinquan

    wuhan univ sci & technol

查看全部 3 位作者收起作者
  • C

    Chen, Cheng (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417